JP2024547090A5 - - Google Patents
Info
- Publication number
- JP2024547090A5 JP2024547090A5 JP2024537471A JP2024537471A JP2024547090A5 JP 2024547090 A5 JP2024547090 A5 JP 2024547090A5 JP 2024537471 A JP2024537471 A JP 2024537471A JP 2024537471 A JP2024537471 A JP 2024537471A JP 2024547090 A5 JP2024547090 A5 JP 2024547090A5
- Authority
- JP
- Japan
- Prior art keywords
- membered
- heterocycloalkyl
- alkylene
- cycloalkyl
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111574916.4 | 2021-12-21 | ||
| CN202111574916 | 2021-12-21 | ||
| CN202210377379 | 2022-04-11 | ||
| CN202210377379.2 | 2022-04-11 | ||
| PCT/CN2022/138955 WO2023116527A1 (zh) | 2021-12-21 | 2022-12-14 | 作为fak抑制剂的化合物及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024547090A JP2024547090A (ja) | 2024-12-26 |
| JP2024547090A5 true JP2024547090A5 (enExample) | 2025-12-22 |
Family
ID=86901291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537471A Pending JP2024547090A (ja) | 2021-12-21 | 2022-12-14 | Ｆａｋ阻害剤としての化合物およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20260159499A1 (enExample) |
| EP (1) | EP4455139A4 (enExample) |
| JP (1) | JP2024547090A (enExample) |
| KR (1) | KR20240128695A (enExample) |
| CN (1) | CN118525015A (enExample) |
| AU (1) | AU2022422848A1 (enExample) |
| CA (1) | CA3238851A1 (enExample) |
| MX (1) | MX2024007629A (enExample) |
| WO (1) | WO2023116527A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026086879A1 (zh) * | 2024-10-25 | 2026-04-30 | 应世生物科技(南京)有限公司 | Fak抑制剂 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2702647C (en) * | 2007-01-31 | 2016-03-22 | Ym Biosciences Australia Pty Ltd | Thiopyrimidine-based compounds and uses thereof |
| WO2009017838A2 (en) * | 2007-08-01 | 2009-02-05 | Exelixis, Inc. | Combinations of jak-2 inhibitors and other agents |
| AR074210A1 (es) * | 2008-11-24 | 2010-12-29 | Boehringer Ingelheim Int | Derivados de pirimidina como inhibidores de ptk2-quinasa |
| BR112016000195A8 (pt) * | 2013-07-11 | 2019-12-31 | Acea Biosciences Inc | compostos heterocíclicos, composição farmacêutica, combinação, seu uso, e método para inibir uma atividade da tirosina quinase btk ou jak, egfr, alk, pdgfr, blk, bmx/etk, flt3(d835y), itk, tec, txk, e suas respectivas vias |
| CN105330698B (zh) * | 2014-07-04 | 2019-05-28 | 齐鲁制药有限公司 | 螺环芳基磷氧化物和硫化物 |
| CN105601631A (zh) * | 2014-10-21 | 2016-05-25 | 北京艾莱英医药科技有限公司 | 2,4-二取代-5-氯嘧啶类衍生物、其制备方法及其在医药上的应用 |
| TWI726363B (zh) * | 2018-07-31 | 2021-05-01 | 大陸商蘇州亞盛藥業有限公司 | Fak/alk/ros1抑制劑與egfr抑制劑的組合治療癌症的方法 |
| CN118574825A (zh) * | 2022-02-28 | 2024-08-30 | 微境生物医药科技(上海)有限公司 | 作为fak抑制剂的化合物及其用途 |
-
2022
- 2022-12-14 CN CN202280084292.4A patent/CN118525015A/zh active Pending
- 2022-12-14 MX MX2024007629A patent/MX2024007629A/es unknown
- 2022-12-14 US US18/709,760 patent/US20260159499A1/en active Pending
- 2022-12-14 CA CA3238851A patent/CA3238851A1/en active Pending
- 2022-12-14 AU AU2022422848A patent/AU2022422848A1/en active Pending
- 2022-12-14 EP EP22909841.3A patent/EP4455139A4/en active Pending
- 2022-12-14 WO PCT/CN2022/138955 patent/WO2023116527A1/zh not_active Ceased
- 2022-12-14 JP JP2024537471A patent/JP2024547090A/ja active Pending
- 2022-12-14 KR KR1020247023925A patent/KR20240128695A/ko active Pending